20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Innospec Inc (IOSP) operates in the SPECIALTY CHEMICALS industry and is headquartered in Englewood, United States with about 2,450 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, IOSP reported $1.8B in revenue and $117M in net income.
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
Interactive charts & full statements → Open the IOSP valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.8B | $1.8B | $1.8B | $1.9B | $2.0B | $1.5B | $1.2B | $1.5B | $1.5B | $1.3B | $883M | $1.0B | $961M | $819M | $776M | $774M | $683M | $598M | $640M | $602M | $532M |
| Gross Profit | $506M | $492M | $543M | $591M | $587M | $435M | $343M | $466M | $435M | $403M | $332M | $346M | $302M | $255M | $236M | $226M | $217M | $189M | $186M | $197M | $187M |
| Gross Margin % | 27.5% | 27.7% | 29.4% | 30.3% | 29.9% | 29.3% | 28.7% | 30.8% | 29.4% | 30.9% | 37.6% | 34.2% | 31.4% | 31.2% | 30.4% | 29.2% | 31.8% | 31.6% | 29.1% | 32.8% | 35.1% |
| Operating Income (EBIT) | $150M | $156M | $178M | $162M | $187M | $132M | $34M | $150M | $134M | $130M | $105M | $156M | $112M | $91M | $98M | $50M | $72M | $21M | $44M | $48M | $32M |
| Operating Margin % | 8.1% | 8.8% | 9.6% | 8.3% | 9.5% | 8.9% | 2.8% | 9.9% | 9.0% | 9.9% | 11.9% | 15.4% | 11.7% | 11.1% | 12.7% | 6.4% | 10.6% | 3.5% | 6.8% | 8.0% | 6.0% |
| Net Income | $122M | $117M | $36M | $139M | $133M | $93M | $29M | $112M | $85M | $62M | $81M | $120M | $84M | $78M | $68M | $49M | $74M | $6M | $12M | $30M | $11M |
| Net Margin % | 6.6% | 6.6% | 1.9% | 7.1% | 6.8% | 6.3% | 2.4% | 7.4% | 5.8% | 4.7% | 9.2% | 11.8% | 8.8% | 9.5% | 8.8% | 6.3% | 10.8% | 1.1% | 1.9% | 4.9% | 2.1% |
| EBITDA | $172M | $187M | $225M | $214M | $226M | $173M | $88M | $206M | $194M | $192M | $144M | $156M | $143M | $115M | $110M | $67M | $90M | $43M | $48M | $89M | $71M |
| Earnings Per Share (EPS) | $4.90 | $4.67 | $1.42 | $5.56 | $5.32 | $3.75 | $1.16 | $4.54 | $3.45 | $2.52 | $3.33 | $4.86 | $3.38 | $3.22 | $2.86 | $1.99 | $2.97 | $0.26 | $0.51 | $1.19 | $0.45 |
| Shares Outstanding (M) | 25M | 25M | 25M | 25M | 25M | 25M | 25M | 25M | 25M | 24M | 24M | 25M | 25M | 24M | 24M | 25M | 25M | 25M | 24M | 25M | 25M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $491M | $453M | $456M | $442M | $440M | $441M | $467M | $443M |
| Gross Profit | $138M | $124M | $127M | $117M | $123M | $125M | $136M | $124M |
| Gross Margin % | 28.1% | 27.3% | 28.0% | 26.4% | 28.0% | 28.4% | 29.2% | 28.0% |
| Operating Income (EBIT) | $40M | $32M | $47M | $31M | $34M | $42M | $41M | $46M |
| Operating Margin % | 8.1% | 7.0% | 10.3% | 7.0% | 7.8% | 9.6% | 8.8% | 10.3% |
| Net Income | $31M | $30M | $47M | $13M | $24M | $33M | ($70M) | $33M |
| Net Margin % | 6.3% | 6.7% | 10.4% | 2.9% | 5.3% | 7.4% | -15.1% | 7.5% |
| EBITDA | $39M | $50M | $60M | $23M | $46M | $54M | $48M | $59M |
| Earnings Per Share (EPS) | $1.25 | $1.22 | $1.91 | $0.52 | $0.94 | $1.31 | $-2.80 | $1.33 |
| Shares Outstanding (M) | 25M | 25M | 25M | 25M | 25M | 25M | 25M | 25M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.8B | $1.8B | $1.7B | $1.7B | $1.6B | $1.6B | $1.4B | $1.5B | $1.5B | $1.4B | $1.2B | $1.0B | $1.0B | $795M | $579M | $569M | $548M | $543M | $494M | $551M | $569M |
| Cash & Cash Equivalents | $250M | $292M | $289M | $204M | $147M | $142M | $105M | $76M | $123M | $90M | $102M | $137M | $42M | $80M | $22M | $81M | $111M | $69M | $14M | $24M | $102M |
| Total Liabilities | $495M | $500M | $519M | $558M | $563M | $538M | $452M | $550M | $648M | $616M | $528M | $425M | $484M | $385M | $262M | $226M | $248M | $386M | $265M | $280M | $344M |
| Total Debt (Short + Long-Term) | $14M | $16M | $14M | $14M | $14M | $12M | $12M | $70M | $209M | $221M | $270M | $134M | $140M | $148M | $30M | $35M | $47M | $56M | $82M | $81M | $148M |
| Total Shareholders' Equity | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B | $944M | $918M | $826M | $794M | $654M | $605M | $516M | $409M | $317M | $343M | $301M | $158M | $229M | $272M | $225M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IOSP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms